intact animal to the cellular, subcellular, and molecular levels. It is published 12 times a year (monthly) by the American lymphatics, including experimental and theoretical studies of cardiovascular function at all levels of organization ranging from the publishes original investigations on the physiology of the heart, blood vessels, and AJP -Heart and Circulatory Physiology Zawieja SD, Wang W, Wu X, Nepiyushchikh ZV, Zawieja DC, Muthuchamy M. Impairments in the intrinsic contractility of mesenteric collecting lymphatics in a rat model of metabolic syndrome. Numerous studies on metabolic syndrome (MetSyn), a cluster of metabolic abnormalities, have demonstrated its profound impact on cardiovascular and blood microvascular health; however, the effects of MetSyn on lymphatic function are not well understood. We hypothesized that MetSyn would modulate lymphatic muscle activity and alter muscularized lymphatic function similar to the impairment of blood vessel function associated with MetSyn, particularly given the direct proximity of the lymphatics to the chronically inflamed adipose depots. To test this hypothesis, rats were placed on a highfructose diet (60%) for 7 wk, and their progression to MetSyn was assessed through serum insulin and triglyceride levels in addition to the expression of metabolic and inflammatory genes in the liver. Mesenteric lymphatic vessels were isolated and subjected to different transmural pressures while lymphatic pumping and contractile parameters were evaluated. Lymphatics from MetSyn rats had significant negative chronotropic effects at all pressures that effectively reduced the intrinsic flow-generating capacity of these vessels by ϳ50%. Furthermore, lymphatics were remodeled to a significantly smaller diameter in the animals with MetSyn. Wire myograph experiments demonstrated that permeabilized lymphatics from the MetSyn group exhibited a significant decrease in force generation and were less sensitive to Ca 2ϩ , although there were no significant changes in lymphatic muscle cell coverage or morphology. Thus, our data provide the first evidence that MetSyn induces a remodeling of collecting lymphatics, thereby effectively reducing their potential load capabilities and impairing the intrinsic contractility required for proper lymph flow.
Impairments in the intrinsic contractility of mesenteric collecting lymphatics in a rat model of metabolic syndrome chronotropic effect; lymphatic muscle; calcium sensitivity THE LYMPHATIC SYSTEM is involved in immune cell trafficking (6, 55) , antigen transport and presentation (32) , fluid and macromolecular homeostasis, oncotic balance, passage of gut satiety signals (44) , and transport of dietary lipids (11, 74) . Proper lymphatic function requires an effective transport of lymph through the lymphatic system and is driven by intrinsic contractility and extrinsic motive forces, failures of which can lead to edema. Studies (31, 61, 75) from recent decades have demonstrated crucial roles of the phasic and tonic contractions of lymphatics in the maintenance of an effective transport of lymph by controlling both lymph driving force (phasic contractions) and vessel resistance to lymph flow (tonic contrac-tions). Muscularized collecting lymphatics drive lymph flow in a "self-regulatory manner" by constantly adjusting their contractility to meet the demands of local fluid loads through pressure-and flow-dependent regulatory mechanisms (8, 10, 29, 48) .
Metabolic syndrome (MetSyn) is defined by a cluster of the following physiological and metabolic abnormalities: overall and central obesity, elevated fasting glucose levels, dyslipidemia, hypertension, and intimal atherogenesis. The resultant progression of MetSyn to cardiovascular disease-linked mortality has lead to the intense study of the physiological consequences of MetSyn and the factors/mechanisms that delineate its pathophysiological characteristics (1, 27) . Aberrant adipokine expression (49) , elevated reactive oxygen species (9, 57) , and chronic inflammatory activation have become hallmarks for MetSyn (23, 39) . Scrutiny of these abnormalities has greatly increased our understanding of the connection between metabolism and inflammation and the consequent increased risk for the development of insulin resistance (7, 22) , endothelial dysfunction (49) , impaired vascular contractility (56) , and cardiovascular disease (1, 27, 34) .
However, the effects of MetSyn on the lymphatic system have not been explored despite the wide overlap of MetSyn pathology with lymphatic function (5, 11, 37 ). The lymphatic system is at the nexus of dietary fat and antigen transport (32, 36, 54, 62, 65, 66) and immune cell priming (6, 55) in addition to its role in fluid and macromolecular homeostasis (8) . The majority of the many inflammatory cytokines and adipokines produced in the adipose pass through the lymphatics (47) . Additionally, there is a positive association between obesity and mild edema (for example, the elevated risk of lymphedema in mastectomy patients in relation to body mass index) and the emerging trend of massive localized lymphedema in the morbidly obese (2, 25, 59) . Several studies (68, 69) have demonstrated that inflammatory mediators, changes in lipid metabolism, and changes in the mechanical load can affect lymphatic pumping activity. Additionally, mesenteric lymphatics are directly exposed to both inflammatory activation and dyslipidemia, in the form of elevated aberrant postprandial chylomicron production (35) and the dietary endotxoins that associate with them (32, 36, 54, 62, 65, 66, 70) . Many inflammatory agents, including endotoxin, are known to modulate lymphatic function (20, 21, 46) . Hence, we hypothesized that MetSyn affects lymphatic pumping activity by altering mechanical load capabilities and modulating lymphatic muscle function.
To test our hypothesis, we used the high-fructose feed (HFF) rat model, which has been previously demonstrated to exhibit MetSyn properties after 7 wk of diet containing 60% fructose (16) . We used both isobaric and isometric functional assess-ments on the lymphatics isolated from the control and MetSyn groups to evaluate their function.
MATERIALS AND METHODS

Animal Handling
Male Sprague-Dawley rats weighing 250 g (ϳ2 mo old) were purchased from Harlan Teklad and given 1 wk to acclimate. A total of 50 rats were separated into two groups, with half of the animals fed a control diet (control group) and the other group (MetSyn group) placed on a HFF diet (60% fructose, ID.89247, Harlan Teklad, 66% caloric content from fructose) for 7 wk under a 12:12-h light-dark cycle to induce MetSyn (51) . Each group was then separated into two experimental groups consisting of 15 rats used for vessel isolation and 10 rats for immunohistochemistry and tissue collection. Water and each respective feed were available ad libitum except during the preexperiment (16 h) fasting period, where only water was available. All animals were housed in an accredited facility by the Association for the Assessment and Accreditation of Laboratory Animal Care and maintained in accordance with the policies defined by the Public Health Service Policy for the Humane Care and Use of Laboratory Animals and the United States Department of Agriculture's Animal Welfare Regulations, and all the protocol were approved by the Texas A&M University Laboratory Animal Care Committee.
Serum Analysis
Blood was collected in fasted (16 h) conscious rats without anesthesia via the lateral saphenous veins at the start and end of the diet period. A 25-gauge needle was used to collect 250 -500 l of blood in a nonheparinized 1.5-ml tube. The collected sample was allowed to clot for 30 min at room temperature before centrifugation at 5,000 g for 15 min. The serum supernatant was removed and stored at Ϫ20°C. Triglyceride and insulin concentrations were assessed through commercially available colorimetric kits (Bioassays ETGA-200) and an insulin ELISA kit (Linco EZMRI-13k) following the manufacturers' protocols.
RT-PCR and Quantitative PCR
Liver samples were collected immediately postmortem for RNA analysis to demonstrate MetSyn induction at the molecular level. RNA was extracted in TRIzol reagent (no. 15596-026, Invitrogen) according to the manufacturer's protocol with slight modifications using 5= Prime Phase Lock Gel tubes (5 Prime 2302830) to assist in-phase separation. Liver-derived RNA was treated with a DNAse kit (AM2222, Ambion), purified using a Genelute Mammalian Total RNA kit (G1N70, Sigma), and then stored at Ϫ80°C. Liver RNA quality and concentration were confirmed using the Agilent 2100 BioAnalyzer and Thermo Nanospec 3000. A sample of 1 g of total liver RNA was converted to cDNA using an Iscript kit (Bio-Rad). Liver cDNA (100 ng) was then processed using SYBR green and amplified using an iCycler Quantitative PCR Analyzer (Bio-Rad) for peroxisome proliferator-activated receptor (PPAR)-␣, sterol regulatory element-binding protein (SREBP)-1C, and TNF-␣ expression with 18S RNA as an internal control, with each forward and reverse primer at 500 nM. Primer sequences were selected from the literature and were as follows: PPAR-␣, forward 5=-TCACACAATGCAATC-CGTTT-3= and reverse 5=-GGCCTTGACCTTGTTCATGT-3= (43); SREBP-1C, forward 5=-ACGGAGCCATGGATTGCACA-3= and reverse 5=-CAAATAGGCCAGGGAAGTC-3= (17); IL-1B, forward 5=-CACCTCTCAAGCAGAGCACAG-3= and reverse 5=-GGGTTCCATG-GTGAAGTCAAC-3= (53); IL-6, forward 5=-TCCTACCCCAACTTC-CAATGCTC-3= and reverse 5=-TTGGATGGTCTTGGTCCTTAGCC-3= (53); TNF-␣, forward 5=-AAATGGGCTCCCTCTCATCAGTTC-3= and reverse 5=-TCTGCTTGGTGGTTTGCTACGAC-3= (53), and 18S RNA, forward 5=-ATGGCCGTTCTTAGTTGGTG-3= and reverse 5=-AACGCCACTTGTCCCTCTAA-3= (43) . SYBR fluorescence was mon-itored each cycle, and the threshold cycle was evaluated and compared with the threshold cycle from 18S RNA (60) . Universal Rat Ref RNA (10.0 ng) was used as a plate-to-plate calibrator.
Perivascular Fat Estimation
Rats from each group were fasted with water access for 16 h and then anesthetized with a combination of Innovar-Vet (0.3 ml/kg im), which is a combination of a droperidol-fentanyl solution [droperidol (20 mg/ml) and fentanyl (0.4 mg/ml)] and diazepam (2.5 mg/kg im). Once rats were anesthetized, a midline incision was made, and a 6-to 7-cm-long loop of the mesenteric bed was exteriorized. The mesenteric bed was stretched flat and photographed using a digital camera connected to the objective of the dissecting scope with a scale in frame for reference. Each photograph contained at least three mesenteric neurovascular bundles from which two pie-shaped arcades could be visualized. The mesenteric arteries were then traced to and along the gut wall. A similar trace was made from the edge of the perivascular adipose tissue, and these measurements were normalized to their corresponding total interartery area (n ϭ 11 arcades from 6 control rats and 22 arcades from 11 MetSyn rats).
Isolated Vessel Preparation and Functional Analyses
After the mesenteric beds were exteriorizing as described above, up to 2 mesenteric lymphatic vessels (MLVs)/animal were carefully isolated from the surrounding tissue, including clearing of all the fat tissue, and then used for either pressurized vessel experiments or myograph analysis. After isolation of the tissue, animals were euthanized with pentobarbital (200 mg/kg). Vessels for pressurized experiments were cannulated and attached to separate pressure reservoirs of albumin-supplemented physiological saline solution (APSS), which contained (in mM) 145.0 NaCl, 4.7 KCl, 2.0 CaCl 2, 1.17 MgSO4, 1.2 NaH 2PO4, 5.0 glucose, 2.0 sodium pyruvate, 0.02 EDTA, and 3.0 MOPS with 1% (wt/vol) BSA. Each vessel was then mounted in a modified Living Systems Instrumentation Single Vessel CH/1 chamber filled with APSS at 38°C, adjusted to its approximate in situ length, and allowed to equilibrate in APSS at a transmural pressure of 1 cmH2O until phasic contractions were observed. The vessel was exposed to transmural pressures of 1, 3, and 5 cmH 2O, and contractile activity was recorded for 5 min each. Finally, passive vessel diameter at each transmural pressure was recorded by switching the bath to Ca 2ϩ -free APSS. MLV diameter traces (n ϭ 17 vessels from 15 control rats and 24 vessels from 15 MetSyn rats) were determined from the video with a vessel wall-tracking program developed and provided by Dr. Michael Davis (15) . Outer lymphatic diameters were tracked at ϳ30 frames/s, providing a trace of diameter changes throughout periods of systole and diastole, which provided the outer end-diastolic and outer end-systolic diameters. The following lymph pump parameters were derived in a manner analogous to vascular and cardiac parameters: the lymphatic tonic index, contraction amplitude, ejection fraction (EF), contraction frequency, fraction pump flow, and systolic/diastolic diameters, as previously described (8) . For experimental comparisons between groups, we used the tonic index and phasic contraction amplitude as the parameters to compare the alterations in the sustained contraction (tone) and phasic contraction strength of the lymphatics, respectively. The tonic index is the percent difference between passive outer lymphatic diameter in Ca 2ϩ -free APSS (normalized to 100%) at that pressure and outer end-diastolic diameter at the same pressure, expressed as a percentage of the passive outer lymphatic diameter. The phasic contraction amplitude was defined as the difference between outer end-diastolic diameter expressed as a percentage of the passive diameter minus the outer end-systolic diameter expressed as a percentage of the passive diameter. 
pCa-Tension Relationships in Permeabilized Lymphatic Segments Solutions
The high-relaxing and pCa solutions used during and after permeabilization of the mesenteric vessels were designed to maintain a desired free Ca 2ϩ concentration, which is presented as pCa values (Ϫlog[Ca 2ϩ ]), using a Ca 2ϩ -EGTA buffering system. The compositions of the solutions were calculated from the Bathe computer program using the binding constants for all ionic species as reported by Godt and Lindley (33) . The high-relaxing solution (pCa Ͼ 9.0) was composed of the following chemicals (in mM): 53.28 KCl, 6.81 MgCl 2, 0.025 CaCl2, 10.0 EGTA, 5.4 Na2ATP, and 12.0 creatine phosphate. The composition of the pCa 4.5 solution was similar to the high-relaxing solution except for the following differences (in mM): 33.74 KCl, 6.48 MgCl 2, and 9.96 CaCl2. The pHs of the high-relaxing and pCa 4.5 solutions were adjusted to 7.0 with KOH, and ionic strength was held constant (0.15). Solutions containing a desired free Ca 2ϩ concentration between pCa 8 and 4.5 were achieved by mixing the appropriate volumes of the high-relaxing and pCa 4.5 solutions based on the Bathe algorithm. All solutions contained the protease inhibitors leupeptin (1 g/ml), pepstatin A (2.5 g/ml), and PMSF (50 M).
Permeabilization. Myograph preparations and experimentation were designed and conducted as previously described (18, 76) . Two stainless steel wires (25.0 m diameter) were passed, one at a time, through the lumen of a 2-mm segment of the isolated mesenteric vessel. The vessel was then transferred to the organ chamber of a single channel wire myograph (model 310A, Danish Myo Technology, Aarhus, Denmark), which contained APSS. One wire was secured to the jaw of the myograph that was under control of an adjustable micrometer, which was used to stretch the vessel between the two parallel wires. The other wire was secured to the other jaw of the myograph, which was coupled to a calibrated force transducer (Danish Myo Technology). The force transducer measured forces between 0 and 30 mN, and the force output was digitized at a sampling frequency of 10 Hz with a PCI-6030e analog-to-digital card and interface (National Instruments, Austin, TX). Experiments were recorded using LabView (National Instruments) at a sampling frequency of 10 Hz and stored on a personal computer (Dell, Austin, TX). Once the vessel was successfully mounted, the myograph was transferred to the stage of an inverted microscope (Olympus CKX41, Leeds Instruments, Irving, TX) coupled to a charge-coupled device camera (model PK-M2U, Hitachi Denshi, Woodbury, NY). A video micrometer (Microcirculation Research Institute, Texas A&M University, College Station, TX) was used to manually measure the inner diameter.
Mesenteric lymphatics were permeabilized by an incubation with 500 U/ml ␣-toxin from Staphylococcus aureus (Calbiochem, San Diego, CA) in pCa 6.0 solution for 30 min at 25°C, as described by Doughtery et al. (18) . After permeabilization, vessels were incubated with 10 M A-23187 (GenBank) for 20 min to deplete intracellular Ca 2ϩ stores (18). 
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Ca 2ϩ -tension protocol. After permeabilization, lymphatic segments (n ϭ 6 vessels for both control and MetSyn animals, 1 vessel/animal) were washed several times with high-relaxing solution and then maximally stimulated at pCa 4.5 (maximum pCa). After this initial activation, permeabilized preparations were washed several times with high-relaxing solution, and force was allowed to stabilize. The pCa-tension relationship was then determined by bathing the permeabilized vessels in solutions of sequentially increasing Ca 2ϩ concentrations, ranging from pCa 8 to 4.5, while force was recorded for ϳ5 min in each solution.
Immunohistochemistry Isolated vessel staining. Rat MLVs were isolated as previously described. After isolation, vessels were gently washed in Dulbecco's PBS (DPBS), pressurized to 3 cmH 2O, and fixed in 2% paraformal-dehyde-DPBS. Vessels were then washed and permeabilized in Ϫ20°C methanol for 5 min before being blocked for 1 h in PBS with 1% BSA and 5% normal goat serum. Lymphatics were then cut in half and incubated overnight with anti-smooth muscle actin (SMA) at 1:500 or normal IgG at the same concentration. Vessels were then stained using goat anti-mouse Alexa 488 (Invitrogen) at 1:200 and imaged using confocal microscopy (n ϭ 4, Leica TCS SP2). z-Axis maximum intensity reconstructions of the lymphatics were prepared using Leica software, and coverage analysis of the lymphatic vessel was performed using ImageJ.
Whole Mount preparation. Rat mesenteric tissue was removed postmortem and pinned out into loops in DPBS. These loops were fixed and permeabilized for 2 h with methanol and blocked in DPBS with 5% goat serum. At this point, mesenteric arcades were cut from the gut wall, and the mesenteric nodal root and arcades were incubated in block solution with mouse anti-rat SMA (Sigma) or normal mouse IgG overnight. Goat anti-mouse Alexa 488 (Invitrogen) was applied for 2 h, and the tissue was mounted on glass slides using antifade reagent (Invitrogen). Lymphatic vessels were determined by morphology and the presence of bulbar valve regions after SMA-positive vessels were traced within the mesentery. Images were taken using confocal microscopy (Leica), and coverage analysis was measured by ImageJ. Maximal intensity projections representative of the data are shown (n ϭ 6 vessels for both control and MetSyn groups, 1 vessel/animal).
Statistics
Quantitative PCR data assessment parameters were determined using a two-tailed Student's t-test. Perivascular adipose expansion was determined with a one-tailed Student's t-test. The pCa-tension relationship was normalized to the tension produced at pCa 4.5 and then fitted to a Hill equation using nonlinear regression analysis to derive the Ca 2ϩ concentration resulting in 50% maximal contraction (pCa50) and the Hill coefficient (the slope of the linear portion of the pCa-tension curve, which represents cooperative activation) using Prism software. Statistical significance in the pressurized vessel ex- periments was determined through two-way ANOVA with Fisher's post hoc analysis by the Statplus (Analystsoft) statistical software package. Data are expressed as means Ϯ SE, and P values of Յ0.05 were considered as significant. Vessel SMA coverage was compared using a two-way Student's t-test.
RESULTS
The HFF Group Exhibited Biochemical and Cellular Characteristics of MetSyn
There were no significant differences in weight gain over the diet period across each group, as previously reported (36); however, an increase in the relative fat deposition in the mesenteric beds of HFF rats was observed ( Fig. 1 ). Quantitative comparisons of perivsacular adipose revealed a modest 22% increase (P ϭ 0.046) in perivascular adipose tissue area expansion bordering the gut wall and mesenteric neurovascular bundles. As shown in Table 1 , the fasting metabolic profiles, such as serum triglyceride and insulin concentrations at the end point of the experiment, significantly increased in HFF rats compared those at the beginning of the experiment. In the control group, fasting serum triglyceride and insulin levels experienced no significant changes over the length of the study. End-point comparisons between the MetSyn and control groups demonstrated a significant increase in the levels of fasting triglyceride and insulin in the serum from MetSyn rats compared with levels in the serum of control rats (n ϭ 15, P Ͻ 0.001). Quantitative PCR analysis demonstrated a significant 50% decrease in PPAR-␣ and a 280% elevation in SREBP-1C expression in liver tissue from the HFF group compared with the control group (Fig. 2) . These changes in lipid metabolism regulator genes were also accompanied by a mild, but significant, twofold elevation in TNF-␣ expression; however, the relative transcript levels of IL-1␤ and IL-6 were not different in liver tissues of the Metsyn group compared with the control group (Fig. 2) . Figure 3 , A and B, shows representative traces of pressurized lymphatics from the control and MetSyn groups. There was a significant reduction in mesenteric lymphatic outer systolic diameters in the MetSyn group at each transmural pressure (Fig. 3D ). In addition, outer diastolic diameters and outer diastolic diameters in Ca 2ϩ -free APSS (Fig. 3, C and E) in the MetSyn group tended to be lower compared with control lymphatics, although this was not significant at P ϭ 0.05. The lymph pump pacemaker was consistently, significantly, and substantially inhibited in MLVs isolated from MetSyn rats compared with control rats, exhibiting a 30 -50% reduction in phasic contraction frequency at each intramural pressure (Fig. 4A ). Lymphatic pump flow and fractional pump flow were the parameters used to assess intrinsic flow production through the product of contraction frequency and stroke volume (SV) or EF. Both lymphatic pump flow and fractional pump flow were significantly lower in MetSyn vessels at all pressures compared with control vessels as a consequence of the reduction in phasic contraction frequency (Fig. 5, C and D) . Phasic contraction amplitude and tonic index values for lymphatic vessels from MetSyn animals had no significant differences from the values for control lymphatics (Fig. 4, B and C) . In addition, as shown in Fig. 5, A and B , SV and EF for lymphatics from the MetSyn group were not significantly affected. Figure 6 , A and B, shows traces of force development at pCa 4.5 for the control and MetSyn groups, respectively. While we observed the peak and plateau components of force development in the control lymphatics as we previously demonstrated (18) , the MetSyn lymphatics did not show distinct peak and plateau components. Maximal stimulated force production at high Ca 2ϩ in the mesenteric lymphatics demonstrated a substantial reduction in force generation (roughly one-half of the control value) from the MetSyn group (P Ͻ 0.001). As shown in Fig. 6 , C and D, the reduction in force production (both peak and plateau components) was consistently observed in the permeabilized lymphatics at Ca 2ϩ concentrations including and above pCa 6.25. Each force generation response was normalized to its maximal force production at pCa 4.5, and the values were fitted to a Hill equation to assess Ca 2ϩ sensitivity and cooperativity for both peak and plateau tensions (Fig. 7, A  and B) . The pCa 50 of permeabilized lymphatics from the MetSyn group was significantly shifted to the right compared with the Ca 2ϩ sensitivity of the control lymphatics, indicating that the Ca 2ϩ sensitivity was significantly decreased in MetSyn lymphatic myofilaments. The pCa 50 was not significantly altered in peak versus plateau curves within both normal and MetSyn groups. In addition, Hill coefficients, representing the cooperative activation of lymphatic myofilament proteins (slope of the linear portion of the pCa-tension curve), were not significantly different between these two groups.
MetSyn Affects Lymphatic Intrinsic Pump Flow
Ca 2ϩ Sensitivity and Force Production Are Decreased in Permeabilized Lymphatics from Animals With MetSyn
Lymphatic Muscle Cell Coverage of MLVs
Whole mount and isolated vessel immunohistochemistry analyses were conducted to determine if muscle cell degeneration or atrophy was involved in the remodeling and contractile reduction observed in MetSyn rats. The whole mount preparations (Fig. 8, A and B) or isolated vessels (Fig. 8, C and D) of mesenteric collecting lymphatic vessels exhibited a similar pattern of qualitative positive staining for actin in both normal and MetSyn groups. In addition, there were no significant quantitative changes in the actin-positive muscle cell coverage on the lymphatic wall (Fig. 8E ).
DISCUSSION
The main goal of this study was to characterize lymphatic function in the MetSyn animal model, and the data presented here provide the first evidence for lymphatic impairment as one of the consequences of diet-induced MetSyn. We observed significant decreases in phasic contractile frequency that reduced the intrinsic lymph pump flow. In addition, the force generation in lymphatic muscle was significantly reduced and was accompanied by decreases in Ca 2ϩ sensitivity in the MetSyn lymphatics. Our results also indicate that the MetSyn microenvironment in the mesenteric bed resulted in a remod-eling of the collecting lymphatics and effectively reduced their potential load capabilities through diameter reduction. Taken together, the induction of MetSyn has a significant impact on both the structure and function of mesenteric collecting lymphatics and suggests a modulation of the ionic and contractile regulatory mechanisms.
Architectural remodeling of the blood microvasculature has long been associated with various chronic inflammatory conditions (14, 24, 38, 40) . In tangent, much attention has now been directed upon lymphatic capillary and collecting vessel function under acute inflammation as these play critical roles in the resolution of edema within the inflamed region (3, 4, 13, 73) and antigen-presenting cell transport (41, 64, 67) . Several studies have reported a rapid and significant expansion of the lymphatic capillaries in association with the disease conditions observed in either 2,4,6-trinitrobenzene sulfonic acid (TNBS) (73)-induced or dextran sodium sulfate (28)-induced models of inflammatory bowel disease (IBD) and hypercholesterolemia (45) . In this study, we observed that prenodal lymphatic collecting vessels in MetSyn rats were significantly smaller in diameter than their control counterparts under pressurized conditions (Fig. 3) . The diameter observations of the lymphatics found in MetSyn are seemingly in contrast with TNBS studies (28, 73) in guinea pigs, where both lymphatic capillaries and collecting vessels exhibited significant increases in their diameters. However, the lymphatic collecting vessel diameter expansion in the TNBS IBD model (73) diminished as vessels were studied from areas more remote from the injection site. The expansion was also transient in nature as vessel diameter returned to control levels within 2 wk. We believe that this discrepancy could be due to the acute local cytotoxicity of the inflammatory compounds. Indeed, the inflammatory activation and cytokine loads within the TNBS-and dextran sodium sulfate-induced models of IBD far exceed the level of inflammation associated with metabolic dysfunction (39, 49) . Taken together, our data (Fig. 2) showing elevated levels of the lipid metabolism regulator genes PPAR-␣ and SREBP-1C along with the inflammatory cytokine TNF-␣ corroborate well with other models of metabolic disorders (43, 51) . Furthermore, the high-fructose diet initiates a chronic system-wide inflammatory condition that begins within the gut and associated adipose tissue, from which these vessels were isolated, and that persists until resolution of the disease (12) .
Metabolic dysfunction has previously been shown to impact lymphatic vessel function and structure. A study of apolipoprotein (Apo)E knockout (ApoE Ϫ/Ϫ ) mice on fed a high-fat diet showed that lymphatic collecting vessels had a loss of lymphatic muscle cells and reduced vessel integrity as assessed by dye uptake and transport (45) . While ApoE Ϫ/Ϫ mice show some features of MetSyn, the degree of dyslipidemia and hypercholesterolemia is more severe than what is observed under high-fructose died-induced MetSyn. Interestingly, both models are thought to induce significant gut permeability alterations and result in elevated dietary endotoxin levels that contribute to disease pathogenesis (16) . Despite this, the HFF model that we used in this study did not significantly decrease lymphatic smooth muscle coverage on lymphatic collecting vessels, nor were there gross changes in their morphology or orientation (Fig. 8) . ApoE, in addition, acts as a ligand for multiple LDL receptor-related proteins, each of which has distinct signaling roles that could be critical factors in the lymphatic muscle cell loss observed in that model (71) . In tangent, the mouse lymphatics have a poor representation of lymphatic muscle cell coverage and morphology with regard to either rat or human collecting lymphatic vessels (30) .
There is a growing consensus that many chronic inflammatory models, such as IBD, nonalcoholic steatohepatitis, and obesity, are heavily impacted by gut flora and bacterial translocation. Fructose diet induction of MetSyn results in a twofold postprandial ApoB 48 chylomicron load (19, 26) , which positively associates with intestinal LPS uptake (32, 63, 72) . High fructose diet feeding, in addition to high-fat diet feeding, increases gut permeability to dietary endotoxin (32, 54) . Dietary endotoxin readily associates with chylomicrons, which are primarily passed through the mesenteric lymphatics (66) along with many other gut peptides and hormones (44) , suggesting that the primary trafficking of LPS is through lymphatic vessels (36, 62, 70, 72) . Lymphatic endothelial cells (42, 52) and lymphatic muscle cells (unpublished observations) express multiple Toll-like receptors, are functionally responsive to LPS, and could potentially modulate their own inflam- ajpheart.physiology.org matory activation (58) . However, more work is needed to uncover the roles of lymphatic function and responsiveness to dietary endotoxin and its role in the progression of these diseases. Through aberrant chylomicron production, MetSyn alters the mechanical characteristics of lymph via changes in viscosity and osmolarity and creates a permissive state for an increased inflammatory profile of the postprandial mesenteric lymph. In conclusion, we speculate that the inflammatory conditions and mechanical stresses in MetSyn contribute to the remodeling of the mesenteric lymphatics and the reduction of vessel diameter.
Mesenteric lymphatics from MetSyn rats exhibited a twofold reduction in their total force production, and their myofilaments were significantly less sensitive to Ca 2ϩ compared with 6 and 7) . Impairments in both smooth and skeletal muscle weakness have been demonstrated in muscle tissue from insulin-resistant models where circulating cytokines are thought to play a critical role (9, 49) . A similar scenario in MetSyn animals in the mesenteric bed would have caused an increase in the fat deposition around the collecting lymphatics and affected the lymphatic muscle function. Ohama et al. (50) have shown that intestinal inflammation caused by TNBS in rats decreases relative levels of PKCpotentiated inhibitor protein of 17 kDa (CPI-17) in intestinal smooth muscle cells and that permeabilized intestine muscle strips exhibit decreases in Ca 2ϩ sensitivity and force generation. The authors (50) have further shown that proinflammatory markers, such as TNF-␣ and IL-1␤, are directly responsible for the decreased levels of CPI-17 in intestinal smooth muscle tissue from TNBS-treated animals, and it has been demonstrated that MetSyn increases circulating TNF-␣ levels (39) . We have previously shown that permeabilization of lymphatic tissue with ␤-escin causes a significant loss of CPI-17 compared with ␣-toxin treatment and that ␤-escin-treated permeabilized lymphatics are less sensitive to Ca 2ϩ (18) and exhibit a reduction in force generation. Further experiments are warranted to demonstrate whether the increasing levels of TNF-␣ in MetSyn cause a decrease in the levels of CPI-17 in lymphatic smooth muscle.
The range of Ca 2ϩ concentrations used in the permeabilization experiments and the concentrations at which significant deviations in force production were observed were outside the normal physiological conditions of intact lymphatic muscle cells, which explains, in part, why the contractile amplitude changes in the intact pressurized vessel experiments were not as severe as those in the permeabilized lymphatics in the myograph experiments. Furthermore, the mechanical conditions of vessels used in the wire myograph experiments may not be directly comparable with those used in the more physiologically relevant isolated pressurized vessels. Lymphatic contractility alterations have previously been documented in an animal model of chemically induced ileitis (73) . In that report (73) , in vivo phasic contractions frequency was reduced, albeit proportionally to the proximity of the injection sites. Additionally, contractile SV was greatly reduced. but these changes were limited only to vessels located near the TNBS injection sites, which corroborate well with our findings from isobaric experiments (73) .
In conclusion, the data presented in this study document the first observations of altered lymphatic contractility and reduced lymphatic muscle function and vessel remodeling by highfructose diet-induced MetSyn. Given the importance of inflammation in the development of MetSyn, it is important to further identify which inflammatory cytokines affect mesenteric lymphatic function under these conditions. This information would provide additional insights in understanding the complex nature of MetSyn and how alterations to the lymphatics play a role in the pathogenesis of this disease.
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